WallStSmart

Covista Inc. (CVSA)vsStride Inc (LRN)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Stride Inc generates 34% more annual revenue ($2.54B vs $1.89B). CVSA leads profitability with a 13.4% profit margin vs 12.1%. LRN appears more attractively valued with a PEG of 0.52. CVSA earns a higher WallStSmart Score of 67/100 (B-).

CVSA

Strong Buy

67

out of 100

Grade: B-

Growth: 5.3Profit: 7.5Value: 7.0Quality: 5.0

LRN

Strong Buy

65

out of 100

Grade: B-

Growth: 4.7Profit: 7.5Value: 8.0Quality: 8.5
Piotroski: 4/9Altman Z: 3.92
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for CVSA.

LRNUndervalued (+15.1%)

Margin of Safety

+15.1%

Fair Value

$101.13

Current Price

$93.08

$8.05 discount

UndervaluedFair: $101.13Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CVSA4 strengths · Avg: 8.0/10
PEG RatioValuation
0.868/10

Growing faster than its price suggests

P/E RatioValuation
16.8x8/10

Attractively priced relative to earnings

Price/BookValuation
2.8x8/10

Reasonable price relative to book value

Operating MarginProfitability
22.9%8/10

Strong operational efficiency at 22.9%

LRN6 strengths · Avg: 8.5/10
Altman Z-ScoreHealth
3.9210/10

Safe zone — low bankruptcy risk

Return on EquityProfitability
20.1%9/10

Every $100 of equity generates 20 in profit

PEG RatioValuation
0.528/10

Growing faster than its price suggests

P/E RatioValuation
14.6x8/10

Attractively priced relative to earnings

Price/BookValuation
2.5x8/10

Reasonable price relative to book value

Operating MarginProfitability
20.8%8/10

Strong operational efficiency at 20.8%

Areas to Watch

CVSA1 concerns · Avg: 4.0/10
EPS GrowthGrowth
4.7%4/10

4.7% earnings growth

LRN2 concerns · Avg: 3.0/10
Revenue GrowthGrowth
2.7%4/10

2.7% revenue growth

EPS GrowthGrowth
-4.5%2/10

Earnings declined 4.5%

Comparative Analysis Report

WallStSmart Research

Bull Case : CVSA

The strongest argument for CVSA centers on PEG Ratio, P/E Ratio, Price/Book. Revenue growth of 12.4% demonstrates continued momentum. PEG of 0.86 suggests the stock is reasonably priced for its growth.

Bull Case : LRN

The strongest argument for LRN centers on Altman Z-Score, Return on Equity, PEG Ratio. PEG of 0.52 suggests the stock is reasonably priced for its growth.

Bear Case : CVSA

The primary concerns for CVSA are EPS Growth.

Bear Case : LRN

The primary concerns for LRN are Revenue Growth, EPS Growth.

Key Dynamics to Monitor

CVSA carries more volatility with a beta of 0.63 — expect wider price swings.

CVSA is growing revenue faster at 12.4% — sustainability is the question.

LRN generates stronger free cash flow (186M), providing more financial flexibility.

Monitor EDUCATION & TRAINING SERVICES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

CVSA scores higher overall (67/100 vs 65/100) and 12.4% revenue growth. LRN offers better value entry with a 15.1% margin of safety. Both earn "Strong Buy" and "Strong Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Covista Inc.

CONSUMER DEFENSIVE · EDUCATION & TRAINING SERVICES · USA

Covista Inc., provides healthcare education in the United States, Barbados, St. Kitts, and St. Maarten. The company is headquartered in Chicago, Illinois.

Stride Inc

CONSUMER DEFENSIVE · EDUCATION & TRAINING SERVICES · USA

Stride, Inc., a technology-based education company, provides its own and third-party online educational services, software systems and curricula to facilitate individualized learning for students primarily in kindergarten through grade 12 (K -12) in the United States and internationally. .

Visit Website →

Want to dig deeper into these stocks?